Myron Holubiak
2021
In 2021, Myron Holubiak earned a total compensation of $1.7M as Chief Executive Officer at Citius Pharmaceuticals, a 91% increase compared to previous year.
Compensation breakdown
| Bonus | $750,000 |
|---|---|
| Non-Equity Incentive Plan | $275,625 |
| Option Awards | $194,978 |
| Salary | $450,000 |
| Total | $1,670,603 |
Holubiak received $750K in bonus, accounting for 45% of the total pay in 2021.
Holubiak also received $275.6K in non-equity incentive plan, $195K in option awards and $450K in salary.
Rankings
In 2021, Myron Holubiak's compensation ranked 6,779th out of 12,405 executives tracked by ExecPay. In other words, Holubiak earned more than 45.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,779 out of 12,405 | 45th |
Division Manufacturing | 2,944 out of 5,494 | 46th |
Major group Chemicals And Allied Products | 1,301 out of 2,369 | 45th |
Industry group Drugs | 1,159 out of 2,090 | 45th |
Industry Pharmaceutical Preparations | 844 out of 1,537 | 45th |
Source: SEC filing on December 20, 2021.
Holubiak's colleagues
We found three more compensation records of executives who worked with Myron Holubiak at Citius Pharmaceuticals in 2021.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018